放射性药物

• ImaginAb completes $12.8 million financing to accelerate growth plans 2021-06-03
• Viewpoint Molecular Targeting(TM) Announces Closing of Its Series A Financing with Proceeds of $13 Million 2021-01-08
• RayzeBio Completes $105M Series B Financing to Advance Targeted Radiopharmaceuticals for Cancer 2020-12-08
• 远大医药拟2500万美元认购Telix约7.6%的股本权益 2020-11-01
• RayzeBio Launches with $45 Million Series A to Advance Portfolio of Targeted Radiopharmaceuticals for Cancer Therapeutics 2020-10-14
• 先通医药获C轮融资，用于放射药项目临床前开发及临床研究 2020-09-08
• Shine Raises $80M in Series C Financing 2020-09-03
• Evergreen Theragnostics Completes $19 Million Series A Capital Raise 2020-06-22
• Progenics Stockholders Approve Merger with Lantheus 2020-06-17
• TAE Life Sciences Raises $30M in Initial Series B Funding 2020-06-03

登录医药魔方官网 查看更多资讯